Proteomics in hematologic malignancies

References

• Blackstock WP, Weir MP. Proteomics: quantitative and physical mapping of cellular proteins. Trends Biotechnol. 17(3), 121–127 (1999).
   PubMed Web of Science ®Google Scholar
• Lutomski D, Caron M, Cornillot JD et al. Identification of different galectins by immunoblotting after two-dimensional polyacrylamide gel electrophoresis with immobilized pH gradients. Electrophoresis 17(3), 600–606 (1996).
   PubMed Web of Science ®Google Scholar
• Lutomski D, Fouillit M, Bourin P et al. Externalization and binding of galectin-1 on cell surface of K562 cells upon erythroid differentiation. Glycobiology 7(8), 1193–1199 (1997).
   PubMed Web of Science ®Google Scholar
• Joubert-Caron R, Feuillard J, Kohanna S et al. A computer-assisted two-dimensional gel electrophoresis approach for studying the variations in protein expression related to an induced functional repression of NFκB in lymphoblastoid cell lines. Electrophoresis 20(4–5), 1017–1026 (1999).
   PubMed Web of Science ®Google Scholar
• Fouillit M, Poirier F, Monostori E et al. Analysis of galectin 1-mediated cell signaling by combined precipitation and electrophoresis techniques. Electrophoresis 21(2), 275–280 (2000).
   PubMed Web of Science ®Google Scholar
• Joubert-Caron R, Le Caer JP, Montandon F et al. Protein analysis by mass spectrometry and sequence database searching: a proteomic approach to identify human lymphoblastoid cell line proteins. Electrophoresis 21(12), 2566–2575 (2000).
   PubMed Web of Science ®Google Scholar
• Poirier F, Imam N, Pontet M, Joubert-Caron R, Caron M. The BPP (protein biochemistry and proteomics) two-dimensional electrophoresis database. J. Chromatogr. B Biomed. Sci. Appl. 753(1), 23–28 (2001).
   PubMedGoogle Scholar
• Poirier F, Pontet M, Labas V et al. Two-dimensional database of a Burkitt lymphoma cell line (DG 75) proteins: protein pattern changes following treatment with 5´- azycytidine. Electrophoresis 22(9), 1867–1877 (2001).
   PubMed Web of Science ®Google Scholar
• Poirier F, Joubert-Caron R, Labas V, Caron M. Proteomic analysis of a lymphoma-derived cell line (DG75) following treatment with a demethylating drug: modification of membrane-associated proteins. Proteomics 3(6), 1028–1036 (2003).
   PubMed Web of Science ®Google Scholar
• Imam-Sghiouar N, Joubert-Caron R, Caron M. Application of metal-chelate affinity chromatography to the study of the phosphoproteome. Amino Acids 28(1), 105–109 (2005).
   PubMed Web of Science ®Google Scholar
• Brockstedt E, Rickers A, Kostka S et al. Identification of apoptosis-associated proteins in a human Burkitt lymphoma cell line. Cleavage of heterogeneous nuclear ribonucleoprotein A1 by caspase 3. J. Biol. Chem. 273(43), 28057–28064 (1998).
   PubMed Web of Science ®Google Scholar
• Gerner C, Frohwein U, Gotzmann J et al. The Fas-induced apoptosis analyzed by high-throughput proteome analysis. J. Biol. Chem. 275(50), 39018–39026 (2000).
   PubMed Web of Science ®Google Scholar
• Thiede B, Siejak F, Dimmler C, Jungblut PR, Rudel T. A two dimensional electrophoresis database of a human Jurkat T-cell line. Electrophoresis 21(13), 2713–2720 (2000).
   PubMed Web of Science ®Google Scholar
• Toda T, Sugimoto M. Proteome analysis of Epstein–Barr virus-transformed B-lymphoblasts and the proteome database. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 787(1), 197–206 (2003).
   PubMed Web of Science ®Google Scholar
• Hanash SM, Madoz-Gurpide J, Misek DE. Identification of novel targets for cancer therapy using expression proteomics. Leukemia 16(4), 478–485 (2002).
   PubMed Web of Science ®Google Scholar
• Cristea IM, Gaskell SJ, Whetton AD. Proteomics techniques and their application to hematology. Blood 103(10), 3624–3634 (2004).
   PubMed Web of Science ®Google Scholar
• Wennborg A, Classon M, Klein G, von Gabain A. Downregulation of c-myc expression after heat shock in human B-cell lines is independent of 5´ mRNA sequences. Biol. Chem. Hoppe Seyler 376(11), 671–680 (1995).
   PubMed Web of Science ®Google Scholar
• Sanchez-Beato M, Sanchez-Aguilera A, Piris MA. Cell cycle deregulation in B-cell lymphomas. Blood 101(4), 1220–1235 (2003).
   PubMed Web of Science ®Google Scholar
• Marano N, Holowka D, Baird B. Bivalent binding of an antiCD3 antibody to Jurkat cells induces association of the T-cell receptor complex with the cytoskeleton. J. Immunol. 143(3), 931–938 (1989).
   PubMed Web of Science ®Google Scholar
• Weis M, Schlegel J, Kass GE et al. Cellular events in Fas/APO-1-mediated apoptosis in JURKAT T-lymphocytes. Exp. Cell Res. 219(2), 699–708 (1995).
   PubMed Web of Science ®Google Scholar
• Schraven B, Peter ME. APO-1(CD95)-mediated apoptosis in Jurkat cells does not involve src kinases or CD45. FEBS Lett. 368(3), 491–494 (1995).
   PubMed Web of Science ®Google Scholar
• Joubert-Caron R, Caron M. Proteome analysis in the study of lymphoma cells. Mass Spectrom. Rev. 24(4), 455–468 (2005).
   PubMed Web of Science ®Google Scholar
• Smith DL, Evans CA, Pierce A, Gaskell SJ, Whetton AD. Changes in the proteome associated with the action of Bcr–Abl tyrosine kinase are not related to transcriptional regulation. Mol. Cell. Proteomics 1(11), 876–884 (2002).
   PubMed Web of Science ®Google Scholar
• Verrills NM, Walsh BJ, Cobon GS, Hains PG, Kavallaris M. Proteome analysis of vinca alkaloid response and resistance in acute lymphoblastic leukemia reveals novel cytoskeletal alterations. J. Biol. Chem. 278(46), 45082–45093 (2003).
   PubMed Web of Science ®Google Scholar
• Verrills NM, Kavallaris M. Drug resistance mechanisms in cancer cells: a proteomics perspective. Curr. Opin. Mol. Ther. 5(3), 258–265 (2003).
   PubMedGoogle Scholar
• Turtinen LW, Prall DN, Bremer LA, Nauss RE, Hartsel SC. Antibody array-generated profiles of cytokine release from THP-1 leukemic monocytes exposed to different amphotericin B formulations. Antimicrob. Agents Chemother. 48(2), 396–403 (2004).
   PubMed Web of Science ®Google Scholar
• Lubbert M. DNA methylation inhibitors in the treatment of leukemias, myelodysplastic syndromes and hemoglobinopathies: clinical results and possible mechanisms of action. Curr. Top. Microbiol. Immunol. 249, 135–164 (2000).
   PubMed Web of Science ®Google Scholar
• Richel DJ, Colly LP, Kluin-Nelemans JC, Willemze R. The antileukaemic activity of 5-Aza-2 deoxycytidine (Aza-dC) in patients with relapsed and resistant leukaemia. Br. J. Cancer 64(1), 144–148 (1991).
   PubMed Web of Science ®Google Scholar
• Silverman LR, Holland JF, Weinberg RS et al. Effects of treatment with 5-azacytidine on the in vivo and in vitro hematopoiesis in patients with myelodysplastic syndromes. Leukemia 7(Suppl. 1), 21–29 (1993).
   PubMed Web of Science ®Google Scholar
• Ben-Bassat H, Goldblum N, Mitrani S et al. Establishment in continuous culture of a new type of lymphocyte from a ‘Burkitt like’ malignant lymphoma (line D.G.-75). Int. J. Cancer 19(1), 27–33 (1977).
   PubMed Web of Science ®Google Scholar
• Poirier F, Bourin P, Bladier D, Joubert-Caron R, Caron M. Effect of 5-azacytidine and galectin-1 on growth and differentiation of the human b lymphoma cell line bl36. Cancer Cell Int. 1(1), 2 (2001).
   PubMedGoogle Scholar
• Chatterjee S, Bhattacharya S. Detoxication of industrial pollutants by the glutathione glutathione-S-transferase system in the liver of Anabas testudineus (Bloch). Toxicol. Lett. 22(2), 187–198 (1984).
   PubMed Web of Science ®Google Scholar
• LaCasse EC, Baird S, Korneluk RG, MacKenzie AE. The inhibitors of apoptosis (IAPs) and their emerging role in cancer. Oncogene 17(25), 3247–3259 (1998).
   PubMed Web of Science ®Google Scholar
• Rickers A, Brockstedt E, Mapara MY et al. Inhibition of CPP32 blocks surface IgM-mediated apoptosis and D4-GDI cleavage in human BL60 Burkitt lymphoma cells. Eur. J. Immunol. 28(1), 296–304 (1998).
   PubMed Web of Science ®Google Scholar
• Rabinovich GA, Riera CM, Sotomayor CE. Galectin-1, an alternative signal for T-cell death, is increased in activated macrophages. Braz. J. Med. Biol. Res. 32(5), 557–567 (1999).
   PubMed Web of Science ®Google Scholar
• Cosma A. Affinity biotinylation: nonradioactive method for specific selection and labeling of cellular proteins. Anal. Biochem. 252(1), 10–14 (1997).
   PubMed Web of Science ®Google Scholar
• Cornillot JD, Pontet M, Dupuy C et al. Production and characterization of a monoclonal antibody able to discriminate galectin-1 from galectin-2 and galectin-3. Glycobiology 8(5), 425–432 (1998).
   PubMed Web of Science ®Google Scholar
• Fouillit M, Joubert-Caron R, Poirier F et al. Regulation of CD45-induced signaling by galectin-1 in Burkitt lymphoma B-cells. Glycobiology 10(4), 413–419 (2000).
   PubMed Web of Science ®Google Scholar
• Faris M, Kokot N, Latinis K et al. The c-Jun N-terminal kinase cascade plays a role in stress-induced apoptosis in Jurkat cells by upregulating Fas ligand expression. J. Immunol. 160(1), 134–144 (1998).
   PubMed Web of Science ®Google Scholar
• Thiede B, Dimmler C, Siejak F, Rudel T. Predominant identification of RNA-binding proteins in Fas-induced apoptosis by proteome analysis. J. Biol. Chem. 276(28), 26044–26050 (2001).
   PubMed Web of Science ®Google Scholar
• Imam-Sghiouar N, Laude-Lemaire I, Labas V et al. Subproteomics analysis of phosphorylated proteins: application to the study of B-lymphoblasts from a patient with Scott syndrome. Proteomics 2(7), 828–838 (2002).
   PubMed Web of Science ®Google Scholar
• Maguire PB, Wynne KJ, Harney DF et al. Identification of the phosphotyrosine proteome from thrombin activated platelets. Proteomics 2(6), 642–648 (2002).
   PubMed Web of Science ®Google Scholar
• Salomon AR, Ficarro SB, Brill LM et al. Profiling of tyrosine phosphorylation pathways in human cells using mass spectrometry. Proc. Natl Acad. Sci. USA 100(2), 443–448 (2003).
   PubMed Web of Science ®Google Scholar
• Blom N, Gammeltoft S, Brunak S. Sequence and structure-based prediction of eukaryotic protein phosphorylation sites. J. Mol. Biol. 294(5), 1351–1362 (1999).
   PubMed Web of Science ®Google Scholar
• Wan J, Wang J, Cheng H et al. Proteomic analysis of apoptosis initiation induced by all-trans retinoic acid in human acute promyelocytic leukemia cells. Electrophoresis 22(14), 3026–3037 (2001).
   PubMed Web of Science ®Google Scholar
• Braziel RM, Shipp MA, Feldman AL et al. Molecular diagnostics. Hematology (Am. Soc. Hematol. Educ. Program) 279–293 (2003).
   PubMedGoogle Scholar
• Hanash SM, Strahler JR, Chan Y et al. Database analysis of protein expression patterns during T-cell ontogeny and activation. Proc. Natl Acad. Sci. USA 90(8), 3314–3318 (1993).
   PubMed Web of Science ®Google Scholar
• Strahler JR, Zhu XX, Hora N et al. Maturation stage and proliferation-dependent expression of dUTPase in human T-cells. Proc. Natl Acad. Sci. USA 90(11), 4991–4995 (1993).
   PubMed Web of Science ®Google Scholar
• Caron M, Imam-Sghiouar N, Poirier F et al. Proteomic map and database of lymphoblastoid proteins. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 771(1–2), 197–209 (2002).
   PubMed Web of Science ®Google Scholar
• Jain KK. Role of oncoproteomics in the personalized management of cancer. Expert Rev. Proteomics 1(1), 49–55 (2004).
   PubMed Web of Science ®Google Scholar
• Lin Z, Jenson SD, Lim MS, Elenitoba-Johnson KS. Application of SELDI-TOF mass spectrometry for the identification of differentially expressed proteins in transformed follicular lymphoma. Mod. Pathol. 17(6), 670–678 (2004).
   PubMed Web of Science ®Google Scholar
• Schasfoort RBM. Proteomics-on-a-chip: the challenge to couple lab-on-a-chip unit operations. Expert Rev. Proteomics 1(1), 123–132 (2004).
   PubMed Web of Science ®Google Scholar
• Ghobrial IM, McCormick DJ, Kaufmann SH et al. Proteomic analysis of mantle-cell lymphoma by protein microarray. Blood 105(9), 3722–3730 (2005).
   PubMed Web of Science ®Google Scholar
• Petricoin EF, Ardekani AM, Hitt BA et al. Use of proteomic patterns in serum to identify ovarian cancer. Lancet 359(9306), 572–577 (2002).
   PubMed Web of Science ®Google Scholar
• Ardekani AM, Liotta LA, Petricoin EF III. Clinical potential of proteomics in the diagnosis of ovarian cancer. Expert Rev. Mol. Diagn. 2(4), 312–320 (2002).
   PubMedGoogle Scholar
• Antonucci F, Chilosi M, Santacatterina M, Herbert B, Righetti PG. Proteomics and immunomapping of reactive lymph-node and lymphoma. Electrophoresis 23(2), 356–362 (2002).
   PubMed Web of Science ®Google Scholar
• Antonucci F, Chilosi M, Parolini C et al. Two-dimensional molecular profiling of mantle cell lymphoma. Electrophoresis 24(14), 2376–2385 (2003).
   PubMed Web of Science ®Google Scholar
• Lin Z, Crockett DK, Jenson SD, Lim MS, Elenitoba-Johnson KS. Quantitative proteomic and transcriptional analysis of the response to the p38 mitogen-activated protein kinase inhibitor SB203580 in transformed follicular lymphoma cells. Mol. Cell. Proteomics 3(8), 820–833 (2004).
   PubMed Web of Science ®Google Scholar
• Harry JL, Wilkins MR, Herbert BR et al. Proteomics: capacity versus utility. Electrophoresis 21(6), 1071–1081 (2000).
   PubMed Web of Science ®Google Scholar
• Bodovitz S, Joos T. The proteomics bottleneck: strategies for preliminary validation of potential biomarkers and drug targets. Trends Biotechnol. 22(1), 4–7 (2004).
   PubMed Web of Science ®Google Scholar